Abstract:Background and Purpose: Delirium is thought to be associated with systemic inflammatory response. However, its association with the most widely used inflammatory biomarker C-reactive protein (CRP) has not been well established. We aimed to examine whether CRP on intensive care unit (ICU) entry was associated with subsequent development of delirium.Design and Setting: This prospective observational study was conducted in a mixed 24-bed ICU in a tertiary teaching hospital.Methods: All patients admitted to the ICU from February 2011 to June 2012 were screened for eligibility. Demographic data and clinical characteristics of included patients were recorded. Patients were screened for the presence of delirium by using the tool Confusion Assessment Method for the ICU (CAM-ICU). C-reactive protein was obtained on ICU entry and 24 hours thereafter. Eligible patients were followed up for 28 days or until death. Univariate and multivariate analyses were performed to evaluate independent risk factors for delirium. Clinical outcome included the length of stay (LOS) in the ICU, 28-day mortality, and duration of mechanical ventilation. Two-tailed P < .05 was considered statistically significant.Results: A total of 223 patients were included during study period. In univariate analysis, patients with delirium showed significantly higher CRP values than those without (120.5 vs 57.5 mg/L; P = .0001). By adjusting for confounding variables (including age, sex, Acute Physiology and Chronic Health Evaluation II, intubation, living alone, physical restraint, alcohol drinking, smoking, type of medical condition, and hospital LOS before ICU admission) in logistic regression model, CRP remained an independent predictor of delirium (odds ratio, 1.07; 95% confidence interval, 1.01-1.15). As compared with nondelirious patients, those with delirium showed longer LOS in ICU (13 vs 5 days; P < .001) and duration of mechanical ventilation (6 vs 1 days; P < .001). An increase in CRP greater than 8.1 mg/L within 24 hours was associated with 4-fold increase in the risk of delirium (odds ratio: 4.47, 95% confidence interval, 1.28-15.60).Conclusion: C-reactive protein measured on ICU entry and its changes within 24 hours are risk indicators of delirium. Further studies exploring the treatment of delirium according to CRP levels are warranted. (C) 2014 Elsevier Inc. All rights reserved.

Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels

Relationship between C-reactive protein and antipsychotics levels in schizophrenic patients infected with COVID-19

Patterns of C-reactive protein trends during clozapine titration and the onset of clozapine-induced inflammation: a case series of weekly and daily C-reactive protein monitoring

Prediction of Delirium in Critically Ill Patients with Elevated C-reactive Protein

Toxic Rise of Clozapine Plasma Concentrations in Relation to Inflammation

New Role of Platelets in Schizophrenia: Predicting Drug Response

Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease

[Therapeutic drug monitoring of antipsychotic drugs in routine psychiatric practice]

The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia.

Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine

Evaluation of major adverse events of clozapine based on accordance to an international titration guideline

Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder

Serum High-Sensitivity C-reactive Protein: A Delicate Sentinel Elevated in Drug-Free Acutely Agitated Patients with Schizophrenia

14:45 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN SCHIZOPHRENIA: READY FOR PRACTICE OR A GOOD START? A META-ANALYSIS

Changes in Serum Interleukin-2, -6, and -8 Levels Before and During Treatment with Risperidone and Haloperidol: Relationship to Outcome in Schizophrenia.

Baseline Levels of C-reactive Protein and Proinflammatory Cytokines Are Not Associated with Early Response to Amisulpride in Patients with First Episode Psychosis: the OPTiMiSE Cohort Study

Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016

Increased Serum Interleukin-8 and Interleukin-10 in Schizophrenic Patients Resistant to Treatment with Neuroleptics and the Stimulatory Effects of Clozapine on Serum Leukemia Inhibitory Factor Receptor

Lower Plasma CC16, a Natural Anti-Inflammatory Protein, and Increased Plasma Interleukin-1 Receptor Antagonist in Schizophrenia: Effects of Antipsychotic Drugs

Increased C‐reactive Protein Concentration and Suicidal Behavior in People with Psychiatric Disorders: A Systematic Review and Meta‐analysis

Immunoinflammatory and Oxidative Alterations in Subjects with Schizophrenia under Clozapine: A Meta-Analysis.